The Royal Free London NHS Foundation Trust is offering up to £50m of work as it develops “one of the five leading global research centres for immunity” targeting cancer and HIV.
The Royal Free charity is seeking expressions of interest on a 36-month framework, worth between £25m and £50m, for its Medical Research and Clinical Trials New Build Phase 2, a new academic building on the trust’s campus in Pond Street, Hampstead.
Phase one is already under way and opens in June. Work is planned to start on phase 2 by 2015.
The scheme will bring together clinical and research expertise focused on developing innovative treatment to improve patient care and give individuals the benefit of advances in medical science.
The trust has said groundbreaking new treatments which have never been available in Europe will be trialled and will target diseases such as cancer and HIV.
The OJEU includes architectural services and engineering services, along with QS, M&E consultant and structural engineer roles.
The trust says teams researching immunology, infection and transplantation “will make Hampstead a hub for medical advances and pioneering care for patients with immune-affected conditions”.
It is backed by the Institute of Immunity, Infection and Transplantation and University College London.
Time limit for receipt of tenders or requests to participate is 28 May. Contact Sandy Mehta on 0207 7940500 or email firstname.lastname@example.org.